L. O'Hearn

Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network

A. DeMaria, M. Cumming, L. Uhl, 2017, Transfusion.

Enhancing hemotherapy safety through pertinent diagnostic testing and electronic “provisional diagnosis” reporting: expanding roles for blood bank technologists in biovigilance and patient safety

L. Eaton, P. Visintainer, A. Knee, 2018, Transfusion.

Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion‐associated circulatory overload have proinflammatory aspects?

J. Steingrub, P. Visintainer, M. Popovsky, 2012, Transfusion.

A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.

M. Sapiano, I. Kracalik, S. Basavaraju, 2021, Transfusion medicine reviews.

Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion‐related adverse reactions in the United States

M. Kuehnert, L. Eaton, M. Cumming, 2018, Transfusion.